Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mod Rheumatol Case Rep ; 4(2): 248-252, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-33086997

RESUMEN

A 52-year-old woman was diagnosed as having anti-centromere antibody (ACA)-positive primary Sjögren syndrome (pSS). Eight years later, she visited our hospital because she had developed dyspnoea. She was diagnosed as having pulmonary arterial hypertension (PAH) with pulmonary veno-occlusive disease on the basis of the results of right heart catheterisation, a severe decrease in diffusing capacity of the lung for carbon monoxide (DLCO, 17%) and desaturation (69%) after a 6-minute walk test. She was also diagnosed as having limited cutaneous systemic sclerosis (lcSSc) because she had developed finger sclerosis. The six-minute walk distance had improved by 54 m 3 months after commencing treatment with tadalafil. Clinicians should be alert to the possibility of patients with ACA-positive SS developing lcSSc and PAH during their clinical course.


Asunto(s)
Anticuerpos Antinucleares/inmunología , Hipertensión Pulmonar/diagnóstico , Hipertensión Pulmonar/etiología , Esclerodermia Limitada/diagnóstico , Esclerodermia Limitada/etiología , Síndrome de Sjögren/complicaciones , Síndrome de Sjögren/inmunología , Autoanticuerpos/inmunología , Autoinmunidad , Biomarcadores , Susceptibilidad a Enfermedades , Femenino , Humanos , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Síndrome de Sjögren/diagnóstico , Síndrome de Sjögren/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA